Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Non Operating Income (2018 - 2025)

Catheter Precision has reported Non Operating Income over the past 8 years, most recently at $2.2 million for Q4 2025.

  • Quarterly Non Operating Income rose 195.87% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 142.9% year-over-year, with the annual reading at -$2000.0 for FY2025, 99.91% up from the prior year.
  • Non Operating Income was $2.2 million for Q4 2025 at Catheter Precision, up from -$5000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $7.5 million in Q4 2023 and troughed at -$2.3 million in Q4 2024.
  • The 5-year median for Non Operating Income is -$2000.0 (2024), against an average of $374833.3.
  • Year-over-year, Non Operating Income soared 39960.0% in 2021 and then plummeted 37475.0% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$19000.0 in 2021, then skyrocketed by 410.53% to $59000.0 in 2022, then skyrocketed by 12672.88% to $7.5 million in 2023, then plummeted by 129.88% to -$2.3 million in 2024, then skyrocketed by 195.87% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Non Operating Income are $2.2 million (Q4 2025), -$5000.0 (Q3 2025), and -$1000.0 (Q2 2025).